MALAT1 and breast carcinoma: It has recently been reported that treatment of ER-negative basal-like breast cancer cell lines with high concentration of 17b-Estradiol (E2) decreased the cellular levels of MALAT1, with a concomitant decrease in cell proliferation, migration and invasion [42].